WAYNE GOODMAN to United States Food and Drug Administration
This is a "connection" page, showing publications WAYNE GOODMAN has written about United States Food and Drug Administration.
Connection Strength
0.211
-
Electroconvulsive therapy in the spotlight. N Engl J Med. 2011 May 12; 364(19):1785-7.
Score: 0.089
-
Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl). 2007 Mar; 191(1):87-96.
Score: 0.066
-
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010 Aug; 71(8):e1-e21.
Score: 0.021
-
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry. 2010 Aug; 71(8):1040-6.
Score: 0.021
-
Suicidality as a possible side effect of antidepressant treatment. J Clin Psychiatry. 2004 Jun; 65(6):742-9.
Score: 0.014